packageAfamelanotide

afamelanotide

Extends from Pharmacolibrary.Interfaces.PartialSubstance (Identity and physicochemical constants of one drug (Drugs.Substances)).

Information

Afamelanotide is a dermatologic drug used to treat erythropoietic protoporphyria, offering systemic protection against UV radiation. It is authorised in the European Union and is also being investigated for other uses.

Summary written by glm-5.3-flash from Wikidata Q410794 and the WHO ATC classification and the EMA medicines list; not checked by a person.

name:afamelanotide
ATC codes:D02BB02
DrugBank:DB04931
PubChem CID:16197727
ChEBI:136034
Wikidata:Q410794
formula:C78H111N21O19
molar mass:1646.87 g/mol (PubChem CID 16197727)
logP:-3.5 (Drugs.Common 25.09, not verified)

Parameters

TypeNameDefaultDescription
Stringname (from PartialSubstance)""INN / common name
String[:]atcCodes (from PartialSubstance)fill("", 0)all WHO ATC codes of the drug
StringdrugbankId (from PartialSubstance)""e.g. DB00758
StringpubchemCid (from PartialSubstance)""PubChem compound id
StringchebiId (from PartialSubstance)""ChEBI id (number)
StringwikidataId (from PartialSubstance)""e.g. Q410238
Stringformula (from PartialSubstance)""molecular formula
Modelica.Units.SI.MolarMassM (from PartialSubstance)0molar mass; 0 = unknown
ReallogP (from PartialSubstance)Modelica.Constants.infoctanol-water partition coefficient (log10); inf = unknown